Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis	Chronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitis	Recruiting	Phase 4	2026-10-07		NCT07862075

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Zhejiang University	201
First Hospital of China Medical University	92
Ruijin Hospital	454
Second Affiliated Hospital of Soochow University	48
Shengjing Hospital	111
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine	2
The Affiliated Hospital of Qingdao University	124
The First Affiliated Hospital of Nanchang University	84
The First Affiliated Hospital of University of Science and Technology of China	31
The First People's Hospital of Yunnan	30
The Third Affiliated Hospital of Soochow University	11
Tianjin Medical University General Hospital	80
Zhongshan Hospital Affiliated to Xiamen University	3
Zunyi Medical College	15

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai	Shanghai	China	4